MoneyWorks4Me

Sandu Pharmaceuticals informs about details of loss of share certificate

21 Jul 2021 Evaluate

Sandu Pharmaceuticals has informed that pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, Link Intime India, the Registrar and Share Transfer Agent (RTA) of the Company has stopped Transfer on receipt of the request for Duplicate issue of Shares for Shareholder, Anil Shah.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.95
Dr. Reddys Labs. 1239.00
Cipla 1329.90
Lupin 1928.00
Zydus Lifesciences 1135.00
View more..